David C Fisher
9PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 26, 2026
A phase 1/2 study of duvelisib plus venetoclax in patients with relapsed/refractory CLL/SLL or Richter transformation.Jennifer L Crombie, Christine E Ryan, Yue Ren
|Apr 17, 2025
Long-term outcomes and clinical phenotypes associated with best response to low dose alemtuzumab in cutaneous T-cell lymphoma.Cecilia Larocca, Ai-Tram N Bui, John T O'Malley
|Apr 03, 2025
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia.James T Yoon, Yinglu Zhou, Mariia Mikhaleva
|Nov 15, 2024
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.Steven M Horwitz, Ajit J Nirmal, Jahan Rahman
|Jun 17, 2024
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.Steven M Horwitz, Ajit J Nirmal, Jahan Rahman
Pageof 2
Frequent Collaborators
4 joint publications
Jennifer R Brown
3 joint publications
Austin I Kim
3 joint publications
Jennifer L Crombie
3 joint publications
Svitlana Tyekucheva
2 joint publications
Marianne Tawa
2 joint publications
Thomas S Kupper
2 joint publications
Christine E Ryan
2 joint publications
Steven M Horwitz
2 joint publications
Matthew S Davids
2 joint publications
Yinglu Zhou